08 Oct 2012, BioSpectrum Bureau , BioSpectrum
Singapore: Transcu Group, a life sciences company engaged in the research, development and commercialization of cutting-edge technologies to improve the quality of life, has appointed Mr Lawrence Rikio Komo as the group's chief executive officer with effect from October 8, 2012, for two years. The appointed follows the retirement of Mr Akihiko Matsumura from the CEO's position on October 5, 2012.
Mr Matsumura will continue to serve on the board as non-executive vice chairman. Mr Komo was appointed independent director of Transcu in November 2011 and stepped up as the chairman of audit committee in May 2012. Mr Komo joined Transcu from Citibank Singapore, where he was managing director within the Securities and Funds Division. Besides Citibank Singapore, Mr Komo has assumed leadership positions in multinational corporations and global banks over the past 20 years.
"I am excited about the opportunities presented to me in leading Transcu Group. During this past year, I have witnessed the dedication and commitment of the management team in finding means to sustain the group's business operations. Transcu is founded on great ideals to improve the quality of human life and we have the patents to proprietary technologies which are capable of achieving the goal. In the next phase, what is required is the execution excellence to bring these technologies to market and this is my utmost priority. Together with the management team, I believe we can navigate through this challenging period towards a brighter future," said Mr Lawrence Rikio Komo.